-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NB6l/h3WSHmcsfvxtm4vcT63yaIHGkIBf62U5Oj1PwsckJZGfkGq8pvOtr7WXMew SNokxgdRoqh4SVi/1usYqg== 0001209191-06-042475.txt : 20060726 0001209191-06-042475.hdr.sgml : 20060726 20060726162256 ACCESSION NUMBER: 0001209191-06-042475 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060725 FILED AS OF DATE: 20060726 DATE AS OF CHANGE: 20060726 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVEN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000815838 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 592767632 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11960 SW 144TH ST CITY: MIAMI STATE: FL ZIP: 33186 BUSINESS PHONE: 3052535099 MAIL ADDRESS: STREET 1: 11960 SW 144TH STREET CITY: MIAMI STATE: FL ZIP: 33185 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EISENBERG JEFFREY F CENTRAL INDEX KEY: 0001224096 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17254 FILM NUMBER: 06981892 BUSINESS ADDRESS: STREET 1: C/O NOVEN PHARMACEUTICALS INC STREET 2: 11960 SW 144TH STREET CITY: MIAMI STATE: FL ZIP: 33186 BUSINESS PHONE: 3052535099 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2006-07-25 0 0000815838 NOVEN PHARMACEUTICALS INC NOVN 0001224096 EISENBERG JEFFREY F C/O NOVEN PHARMACEUTICALS, INC. 11960 S.W. 144TH STREET MIAMI FL 33186 0 1 0 0 Sr. VP - Strategic Alliances Common Stock ($.0001 Par Value) 2006-07-25 4 M 0 18000 10.00 A 21400 D Common Stock ($.0001 Par Value) 2006-07-25 4 S 0 18000 20.00 D 3400 D Stock Options (Right to Buy) 10.00 2006-07-25 4 M 0 18000 0.00 D 2006-11-07 Common Stock ($ .0001 Par Value) 18000 0 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2006. 10% exercisable after 11/08/2000; 20% exercisable after 11/08/2001; 20% exercisable after 11/08/2002; 25% exercisable after 11/08/2003; 25% exercisable after 11/08/2004. /s/ Jeffrey F. Eisenberg 2006-07-26 -----END PRIVACY-ENHANCED MESSAGE-----